These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 21028955)

  • 1. Direct and indirect effectiveness of influenza vaccination delivered to children at school preceding an epidemic caused by 3 new influenza virus variants.
    Glezen WP; Gaglani MJ; Kozinetz CA; Piedra PA
    J Infect Dis; 2010 Dec; 202(11):1626-33. PubMed ID: 21028955
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trivalent live attenuated intranasal influenza vaccine administered during the 2003-2004 influenza type A (H3N2) outbreak provided immediate, direct, and indirect protection in children.
    Piedra PA; Gaglani MJ; Kozinetz CA; Herschler GB; Fewlass C; Harvey D; Zimmerman N; Glezen WP
    Pediatrics; 2007 Sep; 120(3):e553-64. PubMed ID: 17698577
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Universal influenza vaccination and live attenuated influenza vaccination of children.
    Glezen WP
    Pediatr Infect Dis J; 2008 Oct; 27(10 Suppl):S104-9. PubMed ID: 18820568
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Direct and total effectiveness of the intranasal, live-attenuated, trivalent cold-adapted influenza virus vaccine against the 2000-2001 influenza A(H1N1) and B epidemic in healthy children.
    Gaglani MJ; Piedra PA; Herschler GB; Griffith ME; Kozinetz CA; Riggs MW; Fewlass C; Halloran ME; Longini IM; Glezen WP
    Arch Pediatr Adolesc Med; 2004 Jan; 158(1):65-73. PubMed ID: 14706961
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of trivalent, cold-adapted, influenza virus vaccine against influenza A (Fujian), a drift variant, during 2003-2004.
    Halloran ME; Piedra PA; Longini IM; Gaglani MJ; Schmotzer B; Fewlass C; Herschler GB; Glezen WP
    Vaccine; 2007 May; 25(20):4038-45. PubMed ID: 17395338
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Shedding of Ann Arbor strain live attenuated influenza vaccine virus in children 6-59 months of age.
    Mallory RM; Yi T; Ambrose CS
    Vaccine; 2011 Jun; 29(26):4322-7. PubMed ID: 21513761
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness of live attenuated influenza vaccine and inactivated influenza vaccine in children during the 2014-2015 season.
    McLean HQ; Caspard H; Griffin MR; Poehling KA; Gaglani M; Belongia EA; Talbot HK; Peters TR; Murthy K; Ambrose CS
    Vaccine; 2017 May; 35(20):2685-2693. PubMed ID: 28408121
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of Prior Vaccination With Influenza Vaccine Effectiveness in Children Receiving Live Attenuated or Inactivated Vaccine.
    McLean HQ; Caspard H; Griffin MR; Gaglani M; Peters TR; Poehling KA; Ambrose CS; Belongia EA
    JAMA Netw Open; 2018 Oct; 1(6):e183742. PubMed ID: 30646262
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of 1 and 2 doses of live attenuated influenza vaccine in vaccine-naive children.
    Bracco Neto H; Farhat CK; Tregnaghi MW; Madhi SA; Razmpour A; Palladino G; Small MG; Gruber WC; Forrest BD;
    Pediatr Infect Dis J; 2009 May; 28(5):365-71. PubMed ID: 19395948
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the efficacy and safety of live attenuated cold-adapted influenza vaccine, trivalent, with trivalent inactivated influenza virus vaccine in children and adolescents with asthma.
    Fleming DM; Crovari P; Wahn U; Klemola T; Schlesinger Y; Langussis A; Øymar K; Garcia ML; Krygier A; Costa H; Heininger U; Pregaldien JL; Cheng SM; Skinner J; Razmpour A; Saville M; Gruber WC; Forrest B;
    Pediatr Infect Dis J; 2006 Oct; 25(10):860-9. PubMed ID: 17006278
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early Induction of Cross-Reactive CD8+ T-Cell Responses in Tonsils After Live-Attenuated Influenza Vaccination in Children.
    Mohn KG; Brokstad KA; Islam S; Oftung F; Tøndel C; Aarstad HJ; Cox RJ
    J Infect Dis; 2020 Apr; 221(9):1528-1537. PubMed ID: 32255493
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness of Live Attenuated vs Inactivated Influenza Vaccines in Children During the 2012-2013 Through 2015-2016 Influenza Seasons in Alberta, Canada: A Canadian Immunization Research Network (CIRN) Study.
    Buchan SA; Booth S; Scott AN; Simmonds KA; Svenson LW; Drews SJ; Russell ML; Crowcroft NS; Loeb M; Warshawsky BF; Kwong JC
    JAMA Pediatr; 2018 Sep; 172(9):e181514. PubMed ID: 29971427
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness of the 2012/13 trivalent live and inactivated influenza vaccines in children and adolescents in Saxony-Anhalt, Germany: a test-negative case-control study.
    Helmeke C; Gräfe L; Irmscher HM; Gottschalk C; Karagiannis I; Oppermann H
    PLoS One; 2015; 10(4):e0122910. PubMed ID: 25885063
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Seasonal Effectiveness of Live Attenuated and Inactivated Influenza Vaccine.
    Chung JR; Flannery B; Thompson MG; Gaglani M; Jackson ML; Monto AS; Nowalk MP; Talbot HK; Treanor JJ; Belongia EA; Murthy K; Jackson LA; Petrie JG; Zimmerman RK; Griffin MR; McLean HQ; Fry AM
    Pediatrics; 2016 Feb; 137(2):e20153279. PubMed ID: 26738884
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness of influenza vaccine in children in preventing influenza associated hospitalisation, 2018/19, England.
    Pebody RG; Zhao H; Whitaker HJ; Ellis J; Donati M; Zambon M; Andrews N
    Vaccine; 2020 Jan; 38(2):158-164. PubMed ID: 31648914
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of live attenuated influenza vaccine in children: A meta-analysis of nine randomized clinical trials.
    Rhorer J; Ambrose CS; Dickinson S; Hamilton H; Oleka NA; Malinoski FJ; Wittes J
    Vaccine; 2009 Feb; 27(7):1101-10. PubMed ID: 19095024
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effectiveness of seasonal influenza vaccine for adults and children in preventing laboratory-confirmed influenza in primary care in the United Kingdom: 2015/16 end-of-season results.
    Pebody R; Warburton F; Ellis J; Andrews N; Potts A; Cottrell S; Johnston J; Reynolds A; Gunson R; Thompson C; Galiano M; Robertson C; Byford R; Gallagher N; Sinnathamby M; Yonova I; Pathirannehelage S; Donati M; Moore C; de Lusignan S; McMenamin J; Zambon M
    Euro Surveill; 2016 Sep; 21(38):. PubMed ID: 27684603
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alternative Strategy for a Quadrivalent Live Attenuated Influenza Virus Vaccine.
    Wan Z; Cardenas Garcia S; Liu J; Santos J; Carnaccini S; Geiger G; Ferreri L; Rajao D; Perez DR
    J Virol; 2018 Nov; 92(21):. PubMed ID: 30135124
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention and Control of Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices, United States, 2015-16 Influenza Season.
    Grohskopf LA; Sokolow LZ; Olsen SJ; Bresee JS; Broder KR; Karron RA
    MMWR Morb Mortal Wkly Rep; 2015 Aug; 64(30):818-25. PubMed ID: 26247435
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Live attenuated intranasal influenza vaccine.
    Esposito S; Montinaro V; Groppali E; Tenconi R; Semino M; Principi N
    Hum Vaccin Immunother; 2012 Jan; 8(1):76-80. PubMed ID: 22251995
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.